Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study

© 2018 Elsevier Inc. Background: Caprylidene is a ketogen that, when metabolized, produces the ketones beta-hydroxybutyrate and acetoacetate, which can cross the blood brain barrier. It has been hypothesized that ketone bodies can be used as an alternate energy source by neurons with impaired gluco...

Full description

Saved in:
Bibliographic Details
Main Authors: Nare Torosyan, Chakmeedaj Sethanandha, Joshua D. Grill, Michelle L. Dilley, Jooyeon Lee, Jeffrey L. Cummings, Celine Ossinalde, Daniel H. Silverman
Other Authors: Mahidol University
Format: Article
Published: 2019
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/45042
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University